Pasar al contenido principal

MICROESFERAS MULTIDIANA BIODEGRADABLES PARA TERAPIA DE GLAUCOMA. EVALUACION EN UN MODELO ANIMAL DE GLAUCOMA CRONICO

PID2020-113281RB-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO DE INVESTIGACION SANITARIA ARAGON

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Tunable degrees of neurodegeneration in rats based on microsphere‑induced models of chronic glaucoma, Grados ajustables de neurodegeneración en ratas basados ​​en modelos de glaucoma crónico inducidos por microesferas

  • Bravo Osuna, Irene
  • Aragón Navas, Alba
  • García Herranz, David
  • Herrero Vanrell, María Del Rocío
  • Rodrigo María, Jesús
  • Subias, Manuel
  • Montolío, Alberto
  • Cegoñino, José
  • Martínez-Rincón, Teresa
  • Méndez-Martínez, Silvia
  • Pablo Luis, Emilio
  • Pérez del Palomar, Amaya
  • García-Martín, Elena
This study compares four different animal models of chronic glaucoma against normal aging over 6 months. Chronic glaucoma was induced in 138 Long–Evans rats and compared against 43 agedmatched healthy rats. Twenty‑five rats received episcleral vein sclerosis injections (EPIm cohort) while the rest were injected in the eye anterior chamber with a suspension of biodegradable microspheres: 25 rats received non‑loaded microspheres (N‑L Ms cohort), 45 rats received microspheres loaded with dexamethasone (MsDexa cohort), and 43 rats received microspheres co‑loaded with dexamethasone and fibronectin (MsDexaFibro cohort). Intraocular pressure, neuroretinal function, structure and vitreous interface were evaluated. Each model caused different trends in intraocular pressure, produced specific retinal damage and vitreous signals. The steepest and strongest increase in intraocular pressure was seen in the EPIm cohort and microspheres models were more progressive. The EPIm cohort presented the highest vitreous intensity and percentage loss in the ganglion cell layer, the MsDexa cohort presented the greatest loss in the retinal nerve fiber layer, and the MsDexaFibro cohort presented the greatest loss in total retinal thickness. Function decreased differently among cohorts. Using biodegradable microspheres models it is possible to generate tuned neurodegeneration. These results support the multifactorial nature of glaucoma based on several noxa.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Multi‑loaded PLGA microspheres as neuroretinal therapy in a chronic glaucoma animal model, Microesferas de PLGA multicargadas como terapia de la neuroretina en un modelo crónico de glaucoma

  • Aragón Navas, Alba
  • Rodrigo, María Jesús
  • Munuera, Inés
  • García Herranz, David
  • Subías, Manuel
  • Villacampa, Pilar
  • García Feijoo, Julián
  • Pablo, Luis
  • García-Martín, Elena
  • Herrero Vanrell, María Del Rocío
  • Bravo Osuna, Irene
This work focused on the co-encapsulation and simultaneous co-delivery of three different neuroprotective drugs in PLGA (poly(lactic-co-glycolic acid) microspheres for the treatment of glaucoma. For formulation optimization, dexamethasone (anti-inflammatory) and ursodeoxycholic acid (anti-apoptotic) were co-loaded by the solid-in-oil-in-water emulsion solvent extraction-evaporation technique as a first step. The incorporation of a water-soluble co-solvent (ethanol) and different amounts of dexamethasone resulted critical for the encapsulation of the neuroprotective agents and their initial release. The optimized formulation was obtained with 60 mg of dexamethasone and using an 80:20 dichloromethane:ethanol ratio. In the second step in the microencapsulation process, the incorporation of the glial cell line-derived neurotrophic factor (GDNF) was performed. The final prototype showed encapsulation efficiencies for each component above 50% with suitable properties for long-term application for at least 3 months. Physicochemical studies were performed by SEM, TEM, DSC, XRD, and gas chromatography. The evaluation of the kinetic release by the Gallagher-Corrigan analysis with Gorrasi correction helped to understand the influence of the co-microencapsulation on the delivery of the different actives from the optimized formulation. The final prototype was tested in a chronic glaucoma animal model. Rats received two intravitreal injections of the neuroprotective treatment within a 24-week follow-up study. The proposed formulation improved retinal ganglion cell (RGC) functionality examined by electroretinography. Also, it was able to maintain a neuroretinal thickness similar to that of healthy animals scanned by in vivo optical coherence tomography, and a higher RGC count on histology compared to glaucomatous animals at the end of the study.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Laponite for biomedical applications: An ophthalmological perspective

  • Rodrigo, María J.
  • Cardiel, María José
  • Fraile, José M.
  • Mayoral, José A.
  • Pablo-Júlvez, Luis E.
  • García-Martín, Elena
Clay minerals have been applied in biomedicine for thousands of years. Laponite is a nanostructured synthetic clay with the capacity to retain and progressively release drugs. In recent years there has been a resurgence of interest in Laponite application in various biomedical areas. This is the first paper to review the potential biomedical applications of Laponite in ophthalmology. The introduction briefly covers the physical, chemical, rheological, and biocompatibility features of different routes of administration. After that, emphasis is placed on 1) drug delivery for antibiotics, anti-inflammatories, growth factors, other proteins, and cancer treatment; 2) bleeding prevention or treatment; and 3) tissue engineering through regenerative medicine using scaffolds in intraocular and extraocular tissue. Although most scientific research is not performed on the eye, both the findings and the new treatments resulting from that research are potentially applicable in ophthalmology since many of the drugs used are the same, the tissue evaluated in vitro or in vivo is also present in the eye, and the pathologies treated also occur in the eye. Finally, future prospects for this emerging field are discussed., This study was supported by Grants M17/00213, JR22/00057, PI17/01726, PI17/01946, and PI20/00437 (Carlos III Health Institute), and by MAT2017-83858-C2-1, MAT2017-83858-C2-2, PID2020-113281 R B-C2-1, and PID2020-113281 R B-C2-2 funded by (MCIN/AEI/10.13039/501 100 011 033)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Analysis of parainflammation in chronic glaucoma using vitreous-oct imaging

  • Rodrigo, María Jesús
  • Subías, Manuel
  • Montolío, Alberto
  • Méndez-Martínez, Silvia
  • Martínez-Rincón, Teresa
  • Arias, Lorena
  • García-Herranz, David
  • Bravo-Osuna, Irene
  • Garcia-Feijoo, Julián
  • Pablo, Luis
  • Cegoñino, José
  • Herrero-Vanrell, Rocío
  • Carretero, Ana
  • Ruberte, Jesús
  • Garcia-Martin, Elena
  • Pérez Del Palomar, Amaya
Glaucoma causes blindness due to the progressive death of retinal ganglion cells. The immune response chronically and subclinically mediates a homeostatic role. In current clinical practice, it is impossible to analyse neuroinflammation non-invasively. However, analysis of vitreous images using optical coherence tomography detects the immune response as hyperreflective opacities. This study monitors vitreous parainflammation in two animal models of glaucoma, comparing both healthy controls and sexes over six months. Computational analysis characterizes in vivo the hyperreflective opacities, identified histologically as hyalocyte-like Iba-1+ (microglial marker) cells. Glaucomatous eyes showed greater intensity and number of vitreous opacities as well as dynamic fluctuations in the percentage of activated cells (50–250 microns2 ) vs. non-activated cells (10–50 microns2 ), isolated cells (10 microns2) and complexes (>250 microns2 ). Smaller opacities (isolated cells) showed the highest mean intensity (intracellular machinery), were the most rounded at earlier stages (recruitment) and showed the greatest change in orientation (motility). Study of vitreous parainflammation could be a biomarker of glaucoma onset and progression. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Diagnostic ability and capacity of optical coherence tomography-angiography to detect retinal and vascular changes in patients with fibromyalgia

  • Garcia Martin, E.
  • Tello, Á.
  • Vilades, E.
  • Perez-Velilla, J.
  • Cordón, B.
  • Fernandez-Velasco, D.
  • García Campayo, J.
  • Puebla Guedea, M.
  • Satue, M.
Background. To evaluate the neuroretina and retinal vasculature of fibromyalgia (FM) patients and calculate a linear discriminant function (LDF) to improve retinal parameters’ contribution to FM diagnosis. Methods. Fifty FM patients and 232 healthy controls underwent retinal evaluation using swept-source optical coherence tomography (SS-OCT) angiography (Triton plus; Topcon) and spectral domain OCT (SD-OCT) (Spectralis; Heidelberg). The macular (m) and peripapillary (p) retinal nerve fibre layer (RNFL) and ganglion cell layer (GCL) were assessed, as was the macular vascular density. A logistic regression analysis was performed, and an LDF was calculated to evaluate OCT’s contribution to FM diagnosis. Results. With Triton OCT, the patients presented pRNFL thinning in the temporal sector (). Spectralis OCT measurements showed decreased pRNFL in patients in the following sectors: superonasal, ; nasal, ; inferonasal, ; temporal, ; and inferotemporal, . No significant differences were observed in the macular vascular plexus between patients and controls. However, vascular density in the superior sector showed a strong inverse correlation with disease duration (r = −0.978, ). The LDF calculated for Spectralis OCT yielded an area under the ROC curve of 0.968. Conclusions. FM patients present RNFL thinning observable using SS- and SD-OCT. However, these patients show similar vascular density in the macular area to healthy controls. The LDF that combines several RNFL parameters obtained using Spectralis OCT gives this device a powerful ability to differentiate between healthy individuals and individuals with FM.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Tunable degrees of neurodegeneration in rats based on microsphere-induced models of chronic glaucoma

  • Rodrigo, María Jesús
  • Bravo-Osuna, Irene
  • Subias, Manuel
  • Montolío, Alberto
  • Cegoñino, José
  • Martinez-Rincón, Teresa
  • Mendez-Martinez, Silvia
  • Aragón-Navas, Alba
  • Garcia-Herranz, David
  • Pablo, Luis Emilio
  • Herrero-Vanrell, Rocío
  • Pérez del Palomar, Amaya
  • Garcia-Martin, Elena
This study compares four different animal models of chronic glaucoma against normal aging over 6 months. Chronic glaucoma was induced in 138 Long–Evans rats and compared against 43 aged-matched healthy rats. Twenty-five rats received episcleral vein sclerosis injections (EPIm cohort) while the rest were injected in the eye anterior chamber with a suspension of biodegradable microspheres: 25 rats received non-loaded microspheres (N-L Ms cohort), 45 rats received microspheres loaded with dexamethasone (MsDexa cohort), and 43 rats received microspheres co-loaded with dexamethasone and fibronectin (MsDexaFibro cohort). Intraocular pressure, neuroretinal function, structure and vitreous interface were evaluated. Each model caused different trends in intraocular pressure, produced specific retinal damage and vitreous signals. The steepest and strongest increase in intraocular pressure was seen in the EPIm cohort and microspheres models were more progressive. The EPIm cohort presented the highest vitreous intensity and percentage loss in the ganglion cell layer, the MsDexa cohort presented the greatest loss in the retinal nerve fiber layer, and the MsDexaFibro cohort presented the greatest loss in total retinal thickness. Function decreased differently among cohorts. Using biodegradable microspheres models it is possible to generate tuned neurodegeneration. These results support the multifactorial nature of glaucoma based on several noxa.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Assessment of visual function and the neuroretina in subjects diagnosed with congenital anomaly of color vision

  • Garcia-Martin, Elena
  • Fuentes-Bernal, Juan L
  • Otin, Sofia
  • Monreal, Alida
  • Cordon, Beatriz
  • Vilades, Elisa
  • Fuertes-Lazaro, Maria I
This cross-sectional and observational study includes 50 eyes of subjects with color blindness and 50 eyes of control subjects. Visual function (visual acuity, contrast sensitivity, and color vision) and neuroretinal structure were assessed in all subjects using optical coherence tomography (OCT). Significant thinning of the retinal nerve fiber layer, ganglion cell layer, and retina were observed in the color blindness group. Significant thinning was also recorded in layers that involve photoreceptor nuclei (between the outer limiting layer and the Bruch membrane and between the outer plexiform layer and the outer limiting membrane). OCT evaluation based on retinal segmentation is a rapid (5–10 minutes) non-invasive technique and seems to be a good biomarker of color blindness.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Chronic Glaucoma Induced in Rats by a Single Injection of Fibronectin-Loaded PLGA Microspheres: IOP-Dependent and IOP-Independent Neurodegeneration

  • Munuera, Ines
  • Aragon-Navas, Alba
  • Villacampa, Pilar
  • Gonzalez-Cela, Miriam A.
  • Subías, Manuel
  • Pablo, Luis E.
  • Garcia-Feijoo, Julian
  • Herrero-Vanrell, Rocio
  • Garcia-Martin, Elena
  • Bravo-Osuna, Irene
  • Rodrigo, Maria J.
To evaluate a new animal model of chronic glaucoma induced using a single injection of fibronectin-loaded biodegradable PLGA microspheres (Ms) to test prolonged therapies. 30 rats received a single injection of fibronectin-PLGA-Ms suspension (MsF) in the right eye, 10 received non-loaded PLGA-Ms suspension (Control), and 17 were non-injected (Healthy). Follow-up was performed (24 weeks), evaluating intraocular pressure (IOP), optical coherence tomography (OCT), histology and electroretinography. The right eyes underwent a progressive increase in IOP, but only induced cohorts reached hypertensive values. The three cohorts presented a progressive decrease in ganglion cell layer (GCL) thickness, corroborating physiological age-related loss of ganglion cells. Injected cohorts (MsF > Control) presented greater final GCL thickness. Histological exams explain this paradox: the MsF cohort showed lower ganglion cell counts but higher astrogliosis and immune response. A sequential trend of functional damage was recorded using scotopic electroretinography (MsF > Control > Healthy). It seems to be a function–structure correlation: in significant astrogliosis, early functional damage can be detected by electroretinography, and structural damage can be detected by histological exams but not by OCT. Males presented higher IOP and retinal and GCL thicknesses and lower electroretinography. A minimally invasive chronic glaucoma model was induced by a single injection of biodegradable Ms.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Laponite for biomedical applications: An ophthalmological perspective

  • Rodrigo, María J.
  • Cardiel, María J.
  • Fraile, José M.
  • Mayoral, José A.
  • Pablo, Luis E.
  • García-Martin, Elena
Clay minerals have been applied in biomedicine for thousands of years. Laponite is a nanostructured synthetic clay with the capacity to retain and progressively release drugs. In recent years there has been a resurgence of interest in Laponite application in various biomedical areas. This is the first paper to review the potential biomedical applications of Laponite in ophthalmology. The introduction briefly covers the physical, chemical, rheological, and biocompatibility features of different routes of administration. After that, emphasis is placed on 1) drug delivery for antibiotics, anti-inflammatories, growth factors, other proteins, and cancer treatment; 2) bleeding prevention or treatment; and 3) tissue engineering through regenerative medicine using scaffolds in intraocular and extraocular tissue. Although most scientific research is not performed on the eye, both the findings and the new treatments resulting from that research are potentially applicable in ophthalmology since many of the drugs used are the same, the tissue evaluated in vitro or in vivo is also present in the eye, and the pathologies treated also occur in the eye. Finally, future prospects for this emerging field are discussed.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Immune Analysis Using Vitreous Optical Coherence Tomography Imaging in Rats with Steroid-Induced Glaucoma

  • Rodrigo, Maria J.
  • Subías, Manuel
  • Montolío, Alberto
  • Martínez-Rincón, Teresa
  • Aragón-Navas, Alba
  • Bravo-Osuna, Irene
  • Pablo, Luis E.
  • Cegoñino, Jose
  • Herrero-Vanrell, Rocío
  • Garcia-Martin, Elena
  • Pérez del Palomar, Amaya
Glaucoma is a multifactorial pathology involving the immune system. The subclinical immune response plays a homeostatic role in healthy situations, but in pathological situations, it produces imbalances. Optical coherence tomography detects immune cells in the vitreous as hyperreflective opacities and these are subsequently characterised by computational analysis. This study monitors the changes in immunity in the vitreous in two steroid-induced glaucoma (SIG) animal models created with drug delivery systems (microspheres loaded with dexamethasone and dexamethasone/fibronectin), comparing both sexes and healthy controls over six months. SIG eyes tended to present greater intensity and a higher number of vitreous opacities (p < 0.05), with dynamic fluctuations in the percentage of isolated cells (10 µm2), non-activated cells (10–50 µm2), activated cells (50–250 µm2) and cell complexes (>250 µm2). Both SIG models presented an anti-inflammatory profile, with non-activated cells being the largest population in this study. However, smaller opacities (isolated cells) seemed to be the first responder to noxa since they were the most rounded (recruitment), coinciding with peak intraocular pressure increase, and showed the highest mean Intensity (intracellular machinery), even in the contralateral eye, and a major change in orientation (motility). Studying the features of hyperreflective opacities in the vitreous using OCT could be a useful biomarker of glaucoma.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Multi-loaded PLGA microspheres as neuroretinal therapy in a chronic glaucoma animal model

  • Aragón-Navas, Alba
  • Rodrigo, Maria Jesus
  • Munuera, Inés
  • García-Herranz, David
  • Subías, Manuel
  • Villacampa, Pilar
  • García-Feijoo, Julián
  • Pablo, Luis
  • Garcia-Martin, Elena
  • Herrero-Vanrell, Rocio
  • Bravo-Osuna, Irene
This work focused on the co-encapsulation and simultaneous co-delivery of three different neuroprotective drugs in PLGA (poly(lactic-co-glycolic acid) microspheres for the treatment of glaucoma. For formulation optimization, dexamethasone (anti-inflammatory) and ursodeoxycholic acid (anti-apoptotic) were co-loaded by the solid-in-oil-in-water emulsion solvent extraction-evaporation technique as a first step. The incorporation of a water-soluble co-solvent (ethanol) and different amounts of dexamethasone resulted critical for the encapsulation of the neuroprotective agents and their initial release. The optimized formulation was obtained with 60 mg of dexamethasone and using an 80:20 dichloromethane:ethanol ratio. In the second step in the microencapsulation process, the incorporation of the glial cell line-derived neurotrophic factor (GDNF) was performed. The final prototype showed encapsulation efficiencies for each component above 50% with suitable properties for long-term application for at least 3 months. Physicochemical studies were performed by SEM, TEM, DSC, XRD, and gas chromatography. The evaluation of the kinetic release by the Gallagher-Corrigan analysis with Gorrasi correction helped to understand the influence of the co-microencapsulation on the delivery of the different actives from the optimized formulation. The final prototype was tested in a chronic glaucoma animal model. Rats received two intravitreal injections of the neuroprotective treatment within a 24-week follow-up study. The proposed formulation improved retinal ganglion cell (RGC) functionality examined by electroretinography. Also, it was able to maintain a neuroretinal thickness similar to that of healthy animals scanned by in vivo optical coherence tomography, and a higher RGC count on histology compared to glaucomatous animals at the end of the study.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres

  • Rodrigo M.J.
  • Garcia-Herranz D.
  • Aragón-Navas A.
  • Subias M.
  • Martinez-Rincón T.
  • Méndez Martínez S.
  • Cardiel García, M.J.
  • García-Feijoo J.
  • Ruberte J.
  • Herrero-Vanrell R.
  • Pablo Júlvez, L.
  • Garcia Martín, E.
  • Bravo-Osuna I.
Purpose: To evaluate a new chronic glaucoma model produced by intracameral injection of dexamethasone-loaded poly lactic-co-glycolic acid microspheres (Dex-PLGA-Ms) over six months. Methods: Healthy rats received two injections (at baseline and Week 4) of Dex-PLGA-Ms into the anterior chamber of the right eye. Clinical signs and intraocular pressure (IOP) were weekly recorded. The structure of the retina and optic nerve was in vivo evaluated using optical coherence tomography (OCT) every two weeks and functionally using dark- and light-adapted electroretinography at 0–12–24 weeks. Histological studies were also performed. Results: IOP progressively increased up to hypertension (23.22 ± 3.63 mmHg) in both eyes but did so later in left eyes. OCT quantified a decrease in full-thickness retina posterior pole (R), retinal-nerve-fiber layer (RNFL), and ganglion-cell layer (GCL) thickness up to 24 weeks. Right eyes showed higher neuroretinal thickness loss up to week 8. RNFL experienced the highest percentage thickness loss at the inferior-superior axis, while in GCL the inner sectors of the horizontal axis (Nasal-Temporal) suffered the greatest decrease in thickness. Retinal ganglion cell, photoreceptor, and intermediate cell functionality decreased over time. Increased deposition of collagen IV was also found in zonular fibers and the ciliary body. Conclusions: This work shows the usefulness of drug delivery systems, not to treat pathology but to induce it. Only two injections of Dex-PLGA-Ms in the anterior chamber of rat eyes were enough to progressively create ocular hypertension and subsequent functional and structural neuroretinal degeneration, at least over 6 months.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma

  • González-Cela-Casamayor, Ana
  • Rodrigo, María J.
  • Miriam
  • Brugnera, Marco
  • Munuera, Inés
  • Martínez-Rincón, Teresa
  • Prats-Lluís, Catalina
  • Villacampa, Pilar
  • García-Feijoo, Julián
  • Pablo, Luis E.
  • Bravo-Osuna, Irene
  • Garcia-Martin, Elena
  • Herrero-Vanrell, Rocío
Glaucoma is a multifactorial neurodegenerative disease that affects the retina and optic nerve. The aim of this work was to reach different therapeutics targets by co-encapsulating three neuroprotective substances with hypotensive (latanoprost), antioxidant (melatonin) and anti-inflammatory (ketorolac) activity in biodegradable poly (lactic-co-glycolic acid) (PLGA) microspheres (MSs) capable of releasing the drugs for months after intravitreal injection, avoiding the need for repeated administrations. Multi-loaded PLGA MSs were prepared using the oil-in-water emulsion solvent extraction-evaporation technique and physicochemically characterized. PLGA 85:15 was the polymer ratio selected for the selected formulation. Tri-loaded MSs including vitamin E as additive showed good tolerance in retinal pigment epithelium cells after 24 h exposure (>90% cell viability). The final formulation (KMLVE) resulted in 33.58 ± 5.44 µm particle size and drug content (µg/mg MSs) of 39.70 ± 5.89, 67.28 ± 4.17 and 7.51 ± 0.58 for melatonin, ketorolac and latanoprost respectively. KMLVE were able to release in a sustained manner the three drugs over 70 days. KMLVE were injected at 2 and 12 weeks in Long-Evans rats (n = 20) after the induction of chronic glaucoma. Ophthalmological tests were performed and compared to not treated glaucomatous (n = 45) and healthy (n = 17) animals. Treated glaucomatous rats reached the lowest intraocular pressure, enhanced functionality of bipolar and retinal ganglion cells and showed greater neuroretinal thickness by optical coherence tomography (p < 0.05) compared to not treated glaucomatous rats at 24 weeks follow-up. According to the results, the tri-loaded microspheres can be considered as promising controlled-release system for the treatment of glaucoma.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Clues to prognosis in anterior ischemic optic neuropathy: an optical coherence tomography angiography study

  • Rodrigo, Maria J.
  • Pérez-Gómez, Pablo
  • Fuertes, Isabel
  • Pablo, Luis E.
  • Subías, Manuel
  • Casanovas-Marsal, Josep O.
  • Garcia-Martin, Elena
AIM: To investigate optic nerve vascularization in patients with anterior ischemic optic neuropathy (AION) during the first 3mo after onset, using comprehensive ophthalmic assessments combined with optical coherence tomography (OCT) and optical coherence tomography angiography (OCT-A). METHODS: A prospective longitudinal observational study was performed with a 3-month follow-up. Clinical data recorded included age, sex, laterality of ocular involvement, AION subtype, previous history of ischemic events, cardiovascular risk factors such as high blood pressure, dyslipidemia, diabetes mellitus, smoking status, obstructive sleep apnea, and systemic treatments received. Functional, structural, and vascular examinations, including best corrected visual acuity (BCVA), visual field, OCT, and OCT-A, were performed at baseline, 1, and 3mo. RESULTS: Twenty-two subjects included 12 patients with AION and 10 healthy controls were enrolled. Mean age was 63.75±8.32y in the AION group and 61.80±5.04y in the control group (P=0.365). Gender and laterality distributions were comparable. AION patients showed significantly decreased optic nerve head perfusion at baseline (P=0.024) and 1mo (P=0.033). OCT revealed early thickening and subsequent atrophy of the peripapillary retinal nerve fiber layer and macular layers. OCT-A vascular parameters correlated significantly with 1-month BCVA (r=0.800, P≤0.05) and 3-month structural outcomes (r=0.807-0.835, P≤0.05). CONCLUSION: Vascular parameters derived from OCT-A can act as predictive markers for medium-term visual and structural outcomes in patients with ischemic optic neuropathy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Neuroretinal damage associated with pituitary macroadenoma: endocrine and radiological predictors and correlation with optical coherence tomography-derived biomarkers

  • Fernandez-Velasco, Diego
  • Garcia-Martin, Elena
  • Santamaria, Belen
  • Rodrigo, María Jesús
Objective: To identify endocrine and radiological tumor characteristics associated with higher risk of visual impairment. Methods: A retrospective observational study included 40 patients with pituitary macroadenoma. Variables analyzed were age, sex, disease duration, treatment, hormonal profile, tumor volume, and ophthalmic parameters: visual acuity (VA), perimetry, and retinal analysis using optical coherence tomography (OCT). Results: Surgery normalized ACTH, cortisol, IGF-1, and prolactin levels. Larger tumor volumes were observed in males, nonfunctioning tumors, nonoperated patients, and relapses. Larger tumors were associated with worse visual field, while VA remained stable. OCT showed thinning of total retina and inner retinal layers in patients with disease duration >5 years, nonfunctioning tumors, larger tumors, postoperative status, and relapse (p < 0.05). Macular ganglion cell layer thickness correlated inversely with IGF-1 and prolactin, and retinal nerve fiber layer with tumor size. The inner nuclear layer exhibited a non-linear behavior, thickening in early stages while thinning in severe injury. Conclusion: Hormonal and radiological factors are associated with visual dysfunction. OCT and perimetry detect early visual pathway damage better than VA. Non-linear behavior of the INL stand out as a potential prognostic biomarker.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma

  • Rodrigo, María J
  • Brugnera, Marco
  • Munuera, Ines
  • Martínez-Rincón, Teresa
  • Prats-Lluís, Catalina
  • Villacampa, Pilar
  • García Feijoo, Julián
  • Pablo, Luis E
  • Bravo Osuna, Irene
  • Garcia-Martin, Elena
  • Herrero Vanrell, María Del Rocío
  • González-Cela Casamayor, Miriam Ana
Glaucoma is a multifactorial neurodegenerative disease that affects the retina and optic nerve. The aim of this work was to reach different therapeutics targets by co-encapsulating three neuroprotective substances with hypotensive (latanoprost), antioxidant (melatonin) and anti-inflammatory (ketorolac) activity in biodegradable poly (lactic-co-glycolic acid) (PLGA) microspheres (MSs) capable of releasing the drugs for months after intravitreal injection, avoiding the need for repeated administrations. Multi-loaded PLGA MSs were prepared using the oil-in-water emulsion solvent extraction-evaporation technique and physicochemically characterized. PLGA 85:15 was the polymer ratio selected for the selected formulation. Tri-loaded MSs including vitamin E as additive showed good tolerance in retinal pigment epithelium cells after 24 h exposure (>90% cell viability). The final formulation (KMLVE) resulted in 33.58 ± 5.44 µm particle size and drug content (µg/mg MSs) of 39.70 ± 5.89, 67.28 ± 4.17 and 7.51 ± 0.58 for melatonin, ketorolac and latanoprost respectively. KMLVE were able to release in a sustained manner the three drugs over 70 days. KMLVE were injected at 2 and 12 weeks in Long-Evans rats (n = 20) after the induction of chronic glaucoma. Ophthalmological tests were performed and compared to not treated glaucomatous (n = 45) and healthy (n = 17) animals. Treated glaucomatous rats reached the lowest intraocular pressure, enhanced functionality of bipolar and retinal ganglion cells and showed greater neuroretinal thickness by optical coherence tomography (p < 0.05) compared to not treated glaucomatous rats at 24 weeks follow-up. According to the results, the tri-loaded microspheres can be considered as promising controlled-release system for the treatment of glaucoma.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres

  • Rodrigo, MJ.
  • Garcia-Herranz, David|||0000-0003-2092-5927
  • Aragón-Navas, Alba|||0000-0002-7466-8914
  • Subias, M.
  • Martínez-Rincón, Teresa|||0000-0002-8891-0417
  • Mendez-Martínez, S.
  • Cardiel, MJ.
  • García-Feijoo, J.|||0000-0002-7772-5718
  • Ruberte Paris, Jesús|||0000-0003-1540-1432
  • Herrero-Vanrell, Rocío|||0000-0001-9764-7975
  • Pablo, Luis E.|||0000-0003-2389-8282
  • Garcia-Martin, Elena|||0000-0001-6258-2489
  • Bravo-Osuna, Irene|||0000-0003-3133-7872
To evaluate a new chronic glaucoma model produced by intracameral injection of dexamethasone-loaded poly lactic-co-glycolic acid microspheres (Dex-PLGA-Ms) over six months. Healthy rats received two injections (at baseline and Week 4) of Dex-PLGA-Ms into the anterior chamber of the right eye. Clinical signs and intraocular pressure (IOP) were weekly recorded. The structure of the retina and optic nerve was in vivo evaluated using optical coherence tomography (OCT) every two weeks and functionally using dark- and light-adapted electroretinography at 0-12-24 weeks. Histological studies were also performed. IOP progressively increased up to hypertension (23.22 ± 3.63 mmHg) in both eyes but did so later in left eyes. OCT quantified a decrease in full-thickness retina posterior pole (R), retinal-nerve-fiber layer (RNFL), and ganglion-cell layer (GCL) thickness up to 24 weeks. Right eyes showed higher neuroretinal thickness loss up to week 8. RNFL experienced the highest percentage thickness loss at the inferior-superior axis, while in GCL the inner sectors of the horizontal axis (Nasal-Temporal) suffered the greatest decrease in thickness. Retinal ganglion cell, photoreceptor, and intermediate cell functionality decreased over time. Increased deposition of collagen IV was also found in zonular fibers and the ciliary body. This work shows the usefulness of drug delivery systems, not to treat pathology but to induce it. Only two injections of Dex-PLGA-Ms in the anterior chamber of rat eyes were enough to progressively create ocular hypertension and subsequent functional and structural neuroretinal degeneration, at least over 6 months.